MedX Health ( (TSE:MDX) ) has issued an announcement.
MedX Health Corp. has announced a proposed non-brokered private placement to raise up to $2,500,000 through the issuance of 35,714,858 units at $0.07 per unit. Each unit includes a common share and a share purchase warrant, with the placement subject to regulatory approvals and conditions. Additionally, MedX has granted 9,800,000 stock options to directors, officers, employees, and consultants under its Incentive Stock Option Plan, with options exercisable at $0.10 per share and valid for five years. These strategic financial moves aim to bolster the company’s capital and incentivize its workforce, potentially enhancing its market position in the medical device industry.
More about MedX Health
MedX Health Corp., headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health. The company specializes in its SIAscopy® on DermSecure® telemedicine platform and manufactures products like SIAMETRICS®, SIMSYS®, and MoleMate® in its ISO 13485 certified facility.
YTD Price Performance: 7.14%
Average Trading Volume: 168,562
Technical Sentiment Consensus Rating: Sell
Current Market Cap: C$20.42M
See more insights into MDX stock on TipRanks’ Stock Analysis page.